Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis

Japanese Journal of Infectious Diseases

Volumn 57, Issue 6, 2004, Pages 260-263

  Chen, Xuejun ^a   Hiruma, Masataro ^a   Shiraki, Yumi ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; KETOCONAZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ECONOMIC ASPECT; FEMALE; FUNGUS CULTURE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; ONYCHOMYCOSIS; RATING SCALE; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUCONAZOLE; HUMANS; KETOCONAZOLE; MALE; MIDDLE AGED; ONYCHOMYCOSIS;

EID: 13844317849     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Elewski, B. E. (1998): Once-weekly fluconazole in the treatment of onychomycosis: Introduction. J. Am. Acad. Dermatol., 38, 73-76.
2. Elewski, B. E. and Charif, M. A. (1997): Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. Arch. Dermatol., 133, 1172-1173.
3. Millikan, L. E., Powell, D. W. and Drake, L. A. (1999): Quality of life for patients with onychomycosis. Int. J. Dermatol., 38 (Suppl. 2), 13-16.
4. Summerbell, R. C., Kane, J. and Krajden, S. (1989): Onychomycosis, tinea pedis and tinea manuum caused by non-dermatophytic filamentous fungi. Mycosis, 32, 609-619.
5. Zaias, N., Glick, B. and Rebell, G. (1996): Diagnosing and treating onychomycosis. J. Fam. Pract., 42, 513-518.
6. Rich, P., Scher, R. K., Braneman, D., Savin, R. C., Feingold, D. S. and Konnikov, N. (1998): Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail. J. Am. Acad. Dermatol., 38, 103-109.
7. Monteiro-Gei, F., Melendez, M. and Siles, L. (1991): Fluconazole in the treatment of onychomycosis. p. 142. Program and Abstract. The XI Congress of the International Society for Human and Animal Mycology, Montreal, Quebec: ISHAM.
8. Gupta, A. K. and Shear, N. H. (1999): Safety review of the oral antifungal agents used to treat superficial mycosis. Int. J. Dermatol., 38 (Suppl.), 40-52.
9. Goodfield, M. J., Andrew, L. and Evans, E. G. (1992): Short term treatment of dermatophyte onychomycosis with terbinafine. Br. Med. J., 304, 1151-1154.
10. De Doncker, P., Van Lint, J., Dockx, P. and Roseeuw, D. (1995): Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis. Cutis, 56, 180-183.
11. Gupta, A. K., Ryder, J. E. and Johnson, A. M. (2004): Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br. J. Dermatol., 150, 537-544.
12. Finlay, A. Y. (1992): Pharmacokinetics of terbinafine in the nail. Br. J. Dermatol., 126, 28-32.
13. Zaias, N. (1992): Clinical manifestations of onychomycosis. Clin. Exp. Dermatol., 17 (Suppl.), 6-7.
14. Midgley, G., Moore, M. K., Cook, J. C. and Phan, Q. G. (1994): Mycology of nail disorders. J. Am. Acad. Dermatol., 31, 68-74.
15. Hay, R. J. (1993): Onychomycosis, agents of choice. Dermatol. Clin., 11, 161-169.
16. De Doncker, P. (1999): Pharmacokinetics of orally administered antifungals in onychomycosis. Int. J. Dermatol., 38 (Suppl.), 20-27.